bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
aderolio 0.25 mg tabletti
sandoz a/s - everolimuusi - tabletti - 0.25 mg - everolimuusi
aderolio 0.5 mg tabletti
sandoz a/s - everolimuusi - tabletti - 0.5 mg - everolimuusi
aderolio 0.75 mg tabletti
sandoz a/s - everolimuusi - tabletti - 0.75 mg - everolimuusi
aderolio 1 mg tabletti
sandoz a/s - everolimuusi - tabletti - 1 mg - everolimuusi
quinodis 4 mg/ml infuusioneste
f.hoffmann-la roche ltd - fleroxacinum - infuusioneste - 4 mg/ml - fleroksasiini
quinodis 200 mg tabletti
f.hoffmann-la roche ltd - fleroxacinum - tabletti - 200 mg - fleroksasiini
quinodis 400 mg tabletti
f.hoffmann-la roche ltd - fleroxacinum - tabletti - 400 mg - fleroksasiini
fomeda easyhaler 12 mikrog/annos inhalaatiojauhe
orion corporation - formoterol fumarate dihydrate - inhalaatiojauhe - 12 mikrog/annos - formoteroli